| Pharmacokinetic aspects of retinal drug delivery EM Del Amo, AK Rimpelä, E Heikkinen, OK Kari, E Ramsay, T Lajunen, ... Progress in retinal and eye research 57, 134-185, 2017 | 547 | 2017 |
| Barrier analysis of periocular drug delivery to the posterior segment VP Ranta, E Mannermaa, K Lummepuro, A Subrizi, A Laukkanen, ... Journal of Controlled Release 148 (1), 42-48, 2010 | 189 | 2010 |
| Gold-embedded photosensitive liposomes for drug delivery: triggering mechanism and intracellular release L Paasonen, T Sipilä, A Subrizi, P Laurinmäki, SJ Butcher, M Rappolt, ... Journal of Controlled Release 147 (1), 136-143, 2010 | 185 | 2010 |
| Design principles of ocular drug delivery systems: Importance of drug payload, release rate, and material properties A Subrizi, EM Del Amo, V Korzhikov-Vlakh, T Tennikova, M Ruponen, ... Drug discovery today 24 (8), 1446-1457, 2019 | 152 | 2019 |
| Organization of the pronephric kidney revealed by large-scale gene expression mapping D Raciti, L Reggiani, L Geffers, Q Jiang, F Bacchion, AE Subrizi, ... Genome biology 9, 1-21, 2008 | 128 | 2008 |
| Generation of hESC-derived retinal pigment epithelium on biopolymer coated polyimide membranes A Subrizi, H Hiidenmaa, T Ilmarinen, S Nymark, P Dubruel, H Uusitalo, ... Biomaterials 33 (32), 8047-8054, 2012 | 85 | 2012 |
| A critical assessment of in vitro tissue models for ADME and drug delivery KS Vellonen, M Malinen, E Mannermaa, A Subrizi, E Toropainen, YR Lou, ... Journal of Controlled Release 190, 94-114, 2014 | 53 | 2014 |
| Tat (48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake A Subrizi, E Tuominen, A Bunker, T Róg, M Antopolsky, A Urtti Journal of controlled release 158 (2), 277-285, 2012 | 52 | 2012 |
| Oxidative stress protection by exogenous delivery of rhHsp70 chaperone to the retinal pigment epithelium (RPE), a possible therapeutic strategy against RPE degeneration A Subrizi, E Toropainen, E Ramsay, AJ Airaksinen, K Kaarniranta, A Urtti Pharmaceutical research 32, 211-221, 2015 | 51 | 2015 |
| Diffusion and protein corona formation of lipid-based nanoparticles in the vitreous humor: profiling and pharmacokinetic considerations S Tavakoli, OK Kari, T Turunen, T Lajunen, M Schmitt, J Lehtinen, ... Molecular pharmaceutics 18 (2), 699-713, 2020 | 43 | 2020 |
| Extended pharmacokinetic model of the rabbit eye for intravitreal and intracameral injections of macromolecules: quantitative analysis of anterior and posterior elimination … M Lamminsalo, E Taskinen, T Karvinen, A Subrizi, L Murtomäki, A Urtti, ... Pharmaceutical Research 35, 1-14, 2018 | 33 | 2018 |
| Glycosaminoglycan-resistant and pH-sensitive lipid-coated DNA complexes produced by detergent removal method J Lehtinen, Z Hyvönen, A Subrizi, H Bunjes, A Urtti Journal of controlled release 131 (2), 145-149, 2008 | 25 | 2008 |
| Nucleic acid delivery to differentiated retinal pigment epithelial cells using cell-penetrating peptide as a carrier B Subia, M Reinisalo, N Dey, S Tavakoli, A Subrizi, M Ganguli, ... European Journal of Pharmaceutics and Biopharmaceutics 140, 91-99, 2019 | 13 | 2019 |
| Pharmacokinetics of intravitreal macromolecules: Scaling between rats and rabbits A Sadeghi, J Puranen, M Ruponen, A Valtari, A Subrizi, VP Ranta, ... European Journal of Pharmaceutical Sciences 159, 105720, 2021 | 12 | 2021 |
| Extended pharmacokinetic model of the intravitreal injections of macromolecules in rabbits. Part 2: parameter estimation based on concentration dynamics in the vitreous, retina … M Lamminsalo, T Karvinen, A Subrizi, A Urtti, VP Ranta Pharmaceutical Research 37, 1-14, 2020 | 11 | 2020 |
| Screening of chemical linkers for development of pullulan bioconjugates for intravitreal ocular applications A Balasso, A Subrizi, S Salmaso, F Mastrotto, M Garofalo, M Tang, ... European Journal of Pharmaceutical Sciences 161, 105785, 2021 | 10 | 2021 |
| Avoiding the pitfalls of siRNA delivery to the retinal pigment epithelium with physiologically relevant cell models E Ramsay, M Raviña, S Sarkhel, S Hehir, NR Cameron, T Ilmarinen, ... Pharmaceutics 12 (7), 667, 2020 | 7 | 2020 |
| Cowpea chlorotic mottle virus‐like particles as potential platform for antisense oligonucleotide delivery in posterior segment ocular diseases C Pretto, M Tang, M Chen, H Xu, A Subrizi, A Urtti, JCM van Hest Macromolecular Bioscience 21 (8), 2100095, 2021 | 5 | 2021 |
| Intravitreal CendR peptides target laser-induced choroidal neovascularization sites in mice J Puranen, S Korhonen, M Haugas, P Lingasamy, T Teesalu, A Subrizi, ... Journal of Ophthalmology Clinics and Research 360, 810-817, 2023 | 2 | 2023 |
| Tailoring surface properties of liposomes for dexamethasone intraocular administration MD Al-Amin, F Mastrotto, A Subrizi, M Sen, T Turunen, ... Journal of Controlled Release 354, 323-336, 2023 | 2 | 2023 |
